These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Treatment of peripheral arterial disease using stem and progenitor cell therapy. Lawall H; Bramlage P; Amann B J Vasc Surg; 2011 Feb; 53(2):445-53. PubMed ID: 21030198 [TBL] [Abstract][Full Text] [Related]
10. Autologous Cell Therapy for Vascular Regeneration: The Role of Proangiogenic Cells. Bianconi V; Fallarino F; Mannarino MR; Bagaglia F; Kararoudi MN; Aragona CO; Romani R; Pirro M Curr Med Chem; 2018; 25(35):4518-4534. PubMed ID: 29022506 [TBL] [Abstract][Full Text] [Related]
11. Cell therapy in critical limb ischemia: A comprehensive analysis of two cell therapy products. Tournois C; Pignon B; Sevestre MA; Al-Rifai R; Creuza V; Poitevin G; François C; Nguyen P Cytotherapy; 2017 Feb; 19(2):299-310. PubMed ID: 27914820 [TBL] [Abstract][Full Text] [Related]
12. Rationale and design of the MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia in Subjects with Severe Peripheral Arterial Disease (MOBILE) trial investigating autologous bone marrow cell therapy for critical limb ischemia. Wang SK; Green LA; Motaganahalli RL; Wilson MG; Fajardo A; Murphy MP J Vasc Surg; 2017 Jun; 65(6):1850-1857.e2. PubMed ID: 28390770 [TBL] [Abstract][Full Text] [Related]
17. Delivery of placenta-derived mesenchymal stem cells ameliorates ischemia induced limb injury by immunomodulation. Zhang B; Adesanya TM; Zhang L; Xie N; Chen Z; Fu M; Zhang J; Zhang J; Tan T; Kilic A; Li Z; Zhu H; Xie X Cell Physiol Biochem; 2014; 34(6):1998-2006. PubMed ID: 25562148 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic angiogenesis in Buerger's disease (thromboangiitis obliterans) patients with critical limb ischemia by autologous transplantation of bone marrow mononuclear cells. Motukuru V; Suresh KR; Vivekanand V; Raj S; Girija KR J Vasc Surg; 2008 Dec; 48(6 Suppl):53S-60S; discussion 60S. PubMed ID: 19084740 [TBL] [Abstract][Full Text] [Related]
19. Both autologous bone marrow mononuclear cell and peripheral blood progenitor cell therapies similarly improve ischaemia in patients with diabetic foot in comparison with control treatment. Dubsky M; Jirkovska A; Bem R; Fejfarova V; Pagacova L; Sixta B; Varga M; Langkramer S; Sykova E; Jude EB Diabetes Metab Res Rev; 2013 Jul; 29(5):369-76. PubMed ID: 23390092 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Autologous Cell-based Therapy in Patients with No-option Critical Limb Ischaemia: A Meta-Analysis. Wahid FSA; Ismail NA; Wan Jamaludin WF; Muhamad NA; Mohamad Idris MA; Lai NM Curr Stem Cell Res Ther; 2018; 13(4):265-283. PubMed ID: 29532760 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]